Flowability Testing of Directly Compressible Excipients According to British Pharmacopoeia

S  S  Patel; M  S  Patel; N  M  Patel

doi:10.18579/jpcrkc/2009/8/2/79756

Article

Flowability Testing of Directly Compressible Excipients According to British Pharmacopoeia

VIEWS 701
PDF 211

Journal of Pharmaceutical Research

DOI: 10.18579/jpcrkc/2009/8/2/79756

Year: 2009, Volume: 8, Issue: 2, Pages: 66-69

Original Article

Flowability Testing of Directly Compressible Excipients According to British Pharmacopoeia

S. S. Patel *, M. S. Patel , N. M. Patel

Department of Pharmaceutical Technology, Shri B.M.Shah College of Pharmaceutical Education and Research, Dhansura Road, Modasa-383315, Gujarat, India

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Flowability and packability of thirteen commercially available, direct compression excipients, Avicel CE-15, Prosolv SMCC HD-90, Prosolv SMCCTM-90, Tablettose 80, Flowlac 100, Cellactose 80, Microcelac 100, Ludipress, Ludipress-LCE, Emcompress, Starch 1500 G, Era Tab and Maize starch-B were examined according to the technical procedure described in the current British Pharmacopoeia. Results revealed unfavorable properties for Ludipress compared to other substances. Ludipress, however, appeared macroscopically to be of extremely pronounced free flowing properties. This contraindication was studied in more detail, proposing to express powder flow in terms of volume per time unit rather than mass time unit (Volume-flowability). Avicel CE-15, Starch 1500 G, Era Tab and Maize starch B exhibited "poor" flow property.